Skip to Content

Nimotuzumab

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0828933-51-3

Chemical Formula

C6566-H10082-N1746-O2056-S40

Therapeutic Categories

Antineoplastic agent

Monoclonal antibody, binding to the Epidermal Growth Factor Receptor (EGFR)

Chemical Name

Immunoglobulin G1, anti-(humanized mouse monoclonal hR3 β1 chain anti-human epidermal growth factor receptor), disulfide with humanized mouse monoclonal hR3 kappa-chain, dimer (WHO )

Foreign Names

  • Nimotuzumabum (Latin)
  • Nimotuzumab (German)
  • Nimotuzumab (French)
  • Nimotuzumab (Spanish)

Generic Names

  • Cimazumab (IS)
  • h-R3 (IS)

Brand Names

  • Taixinsheng
    Baitai Pharmaceutical, China
  • Theracim
    Innogene Kalbiotech, Indonesia; Innogene Kalbiotech, Philippines; Innogene Kalbiotech, Thailand

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide